(2) The osmotic natriuresis, diuretic, and blood volume-reducing effects of SGLT2 inhibitors, particularly when used in combination with diuretics, may result in a relative insufficiency of effective blood volume in T2DM patients, thereby increasing the risk of AKI (42). This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.